MusclePharm Corporation Stock

Stocks

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/09/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
19/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
29/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
23/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/29/22 A	White Winston Select Asset Funds LLC	Sell	Company	626,826	1.8775%
12/21/21 A	Sabina Rizvi	Free	Chairperson	1,811,000	5.4244%
4/1/21 A	Sabina Rizvi	Other	President & CFO	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	-.--%	-.--%	-	-	33
CHURCHILL CAPITAL CORP XI	-3.29%	-12.17%	-	-	813M
CENTIEL AG	+6.40%	-1.69%	+310.59%	-68.56%	668M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	+0.10%	-	-	645M
CHURCHILL CAPITAL CORP XII	0.00%	-0.42%	-	-	595M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.29%	+0.78%	-	-	602M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	-0.29%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.45%	+0.78%	-	-	569M
CHURCHILL CAPITAL CORP XIII	-0.76%	-1.70%	-	-	507M
Average	+0.75%	-1.94%	+310.59%	-68.56%	624.05M
Weighted average by Cap.	+0.76%	-2.33%	+310.59%	-68.56%